Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.550
-0.056 (-2.15%)
Jan 28, 2026, 4:00 PM EST - Market closed
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2024. The number of employees decreased by 20 or -90.91% compared to the previous year.
Employees
2
Change (1Y)
-20
Growth (1Y)
-90.91%
Revenue / Employee
$1,500
Profits / Employee
-$3,110,000
Market Cap
9.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | -20 | -90.91% | 2 | 0 |
| Dec 31, 2023 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2022 | 29 | 4 | 16.00% | 28 | 1 |
| Dec 31, 2021 | 25 | 3 | 13.64% | 24 | 1 |
| Dec 31, 2020 | 22 | -1 | -4.35% | 20 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| BiomX | 57 |
| CytoMed Therapeutics | 43 |
| SeaStar Medical Holding | 19 |
| BioVie | 13 |
| BioRestorative Therapies | 11 |
| XTL Biopharmaceuticals | 10 |
| Immuron | 7 |
PULM News
- 5 weeks ago - Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives - PRNewsWire
- 3 months ago - Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PRNewsWire
- 6 months ago - Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets - PRNewsWire
- 9 months ago - Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets - PRNewsWire
- 9 months ago - PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM - Business Wire
- 11 months ago - Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - PRNewsWire
- 1 year ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - Accesswire
- 1 year ago - Pulmatrix and Cullgen Announce Proposed Merger - PRNewsWire